Johnson & Johnson JNJ has settled its California talc case midtrial and is likely to avoid a huge judgement, according to Law 360.
Alameda County Superior Court Judge Stephen Kaus in Oakland, California reportedly made the announcement to the jury today.
Johnson & Johnson has faced more than 14,000 claims that its talc powder caused ovarian cancer and mesothelioma, a rare cancer linked to asbestos exposure.
In December, a jury in Los Angeles sided with the company in the case of Amy Fong, who alleged Johnson & Johnson’s talc contained asbestos and caused her to develop mesothelioma, reports the Fierce Pharma.
Johnson & Johnson shares were down 0.49% at $143.59 at the time of publication. The stock has a 52-week high of $148.99 and a 52-week low of $121.
Related Links:
Johnson & Johnson Voluntarily Recalls A Batch Of Baby Powder
Johnson & Johnson Trades Higher On Q3 Beat-And-Raise, Despite Legal Entanglements
Public domain photo via Wikimedia.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.